Your browser doesn't support javascript.
loading
Antileishmanial Activity of Flavones-Rich Fraction From Arrabidaea chica Verlot (Bignoniaceae).
Silva-Silva, João Victor; Moragas-Tellis, Carla Junqueira; Chagas, Maria do Socorro Dos Santos; de Souza, Paulo Victor Ramos; de Souza, Celeste da Silva Freitas; Hardoim, Daiana de Jesus; Taniwaki, Noemi Nosomi; Moreira, Davyson de Lima; Dutra Behrens, Maria; Calabrese, Kátia da Silva; Almeida-Souza, Fernando.
Afiliação
  • Silva-Silva JV; Laboratory of Immunomodulation and Protozoology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Moragas-Tellis CJ; Laboratory of Natural Products for Public Health, Pharmaceutical Techonology Institute - Farmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Chagas MDSDS; Laboratory of Natural Products for Public Health, Pharmaceutical Techonology Institute - Farmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • de Souza PVR; Laboratory of Natural Products for Public Health, Pharmaceutical Techonology Institute - Farmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • de Souza CDSF; Student on Postgraduate Program in Translational Research in Drugs and Medicines, Farmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Hardoim DJ; Laboratory of Immunomodulation and Protozoology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Taniwaki NN; Laboratory of Immunomodulation and Protozoology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Moreira DL; Electron Microscopy Nucleus, Adolfo Lutz Institute, São Paulo, Brazil.
  • Dutra Behrens M; Laboratory of Natural Products for Public Health, Pharmaceutical Techonology Institute - Farmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Calabrese KDS; Laboratory of Natural Products for Public Health, Pharmaceutical Techonology Institute - Farmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Almeida-Souza F; Laboratory of Immunomodulation and Protozoology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Front Pharmacol ; 12: 703985, 2021.
Article em En | MEDLINE | ID: mdl-34354593
Acknowledging the need of identifying new compounds for the treatment of leishmaniasis, this study aimed to evaluate, from in vitro trials, the activity of flavones from Arrabidaea chica against L. amazonensis. The chromatographic profiles of the hydroethanolic extract and a flavone-rich fraction (ACFF) from A. chica were determined by high-performance liquid chromatography coupled with a diode-array UV-Vis detector (HPLC-DAD-UV) and electrospray ionization mass spectrometry in tandem (LC-ESI-MS-MS). The flavones luteolin (1) and apigenin (2), isolated from chromatographic techniques and identified by Nuclear Magnetic Resonance of 1H and 13C, were also quantified in ACFF, showing 190.7 mg/g and apigenin 12.4 mg/g, respectively. The other flavones were identified by comparing their spectroscopic data with those of the literature. The in vitro activity was assayed against promastigotes and intramacrophagic amastigote forms of L. amazonensis. Cytotoxicity tests were performed with peritoneal macrophages of BALB/c mice. Nitrite quantification was performed with Griess reagent. Ultrastructural investigations were obtained by transmission electron microscopy. Anti-Leishmania assays indicated that the IC50 values for ACFF, apigenin, and luteolin were obtained at 40.42 ± 0.10 and 31.51 ± 1.13 µg/mL against promastigotes, respectively. ACFF and luteolin have concentration-dependent cytotoxicity. ACFF and luteolin also inhibited the intra-macrophagic parasite (IC50 3.575 ± 1.13 and 11.78 ± 1.24 µg/mL, respectively), with a selectivity index of 11.44 for ACFF. Promastigotes exposed to ACFF and luteolin exhibited ultrastructural changes, such as intense cytoplasm vacuolization and mitochondrial swelling. These findings data evidence the antileishmanial action of flavone-rich fractions of A. chica against L. amazonensis, encouraging further studies.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Brasil País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Brasil País de publicação: Suíça